2005
DOI: 10.1007/bf02985577
|View full text |Cite
|
Sign up to set email alerts
|

Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer

Abstract: These results suggest that FDG-PET and CT appear to have a complementary role in the detection of distant metastasis in patients with pancreatic cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
22
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 62 publications
(22 citation statements)
references
References 14 publications
0
22
0
Order By: Relevance
“…Restrictive inclusion criteria may be a limitation of this study; however, we think that rigorous staging workups are important to exclude patients with occult distant metastases to increase the survival of patients treated by RT. Use of PET/CT is still prone to false-negative results, especially in terms of detecting liver metastasis or peritoneal seeding (28)(29)(30). In the present study, many distant metastases (13 cases among 18 patients) were detected within 12 months of diagnosis, and it is possible that these 13 patients had synchronous undetectable metastatic disease at diagnosis.…”
Section: Discussionmentioning
confidence: 99%
“…Restrictive inclusion criteria may be a limitation of this study; however, we think that rigorous staging workups are important to exclude patients with occult distant metastases to increase the survival of patients treated by RT. Use of PET/CT is still prone to false-negative results, especially in terms of detecting liver metastasis or peritoneal seeding (28)(29)(30). In the present study, many distant metastases (13 cases among 18 patients) were detected within 12 months of diagnosis, and it is possible that these 13 patients had synchronous undetectable metastatic disease at diagnosis.…”
Section: Discussionmentioning
confidence: 99%
“…It is recommended by HATFIELD et al to routinely use the bone scan to evaluate patients with carcinoma of the pancreas based on a detection rate of 6% (9). Besides, Positron Emission Tomography (PET) scan is useful to determine the primary tumours because the primary carcinomas in 30% of patients cannot be identified when bone metastases are first diagnosed (10).…”
Section: Discussionmentioning
confidence: 99%
“…27 The principle of FDG-PET imaging is, again, not tumor-specifi c. Whether this method is superior to CT or MRI for the differential diagnosis of pancreatic cancer is a matter of discussion. [28][29][30][31] The present method of molecular imaging scintigraphy for pancreatic cancer detects KL-6, an extracellular epitope of the tumorspecifi c glycosylated protein MUC1. Therefore, use of this method for diagnosis in human subjects can be benefi cial for arriving at a precise diagnosis and deciding on a treatment program.…”
Section: Discussionmentioning
confidence: 99%